Skip to main content
Premium Trial:

Request an Annual Quote

Meanwhile, the Pricing Folks at Nature and Science Rejoice

Peter Suber, who spends his days thinking about open access issues, posted this entry on his blog -- it's an excerpt from a press release issued by Yale explaining its libraries' decision to stop supporting BioMed Central's Open Access publishing effort. The problem was financial: the libraries paid for the author page charges, which allowed those papers to be freely available online. The first year's charges came in under $5,000 but soared to more than $31,000 in 2006, the second year. This year looks to continue that trend, the libraries said, adding that the business model was "unsustainable" and "failed to provide a viable long-term revenue base built upon logical and scalable options," according to the press release.

Looks like it's back to the drawing board for at least some open-access proponents.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.